Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Arbele Announces Strategic Collaborations on AI Precision Oncology and Manufacturing to Advance CDH17-Targeted Immunotherapeutics 2024-10-09 23:00
Nona Biosciences Enters Strategic Collaboration with OverT Bio to Advance Next-Generation Cell Therapies for Solid Tumors 2024-10-09 20:00
Alpha Fusion Accelerates Astatine-based Drug Discovery with Series B Funding 2024-10-09 15:23
The CDE has Granted Breakthrough Therapy Designation to LBL-024, a Bispecific Antibody that Targets PD-L1 and 4-1BB, Developed by Leads Biolabs, for the Treatment of Extrapulmonary Neuroendocrine Carcinoma. 2024-10-09 13:38
The CDE has Granted Breakthrough Therapy Designation to LBL-024, a Bispecific Antibody that Targets PD-L1 and 4-1BB, Developed by Leads Biolabs, for the Treatment of Extrapulmonary Neuroendocrine Carcinoma. 2024-10-09 13:32
Joint Venture Company Established for Incubation of Early Drug Discovery Programs; Investment from Takeda, Astellas and Sumitomo Mitsui Banking 2024-10-09 10:00
AWAK Transforms into Vivance, Unveiling a New Brand Identity 2024-10-09 08:00
LakeShore Biopharma Provides Fiscal Half Year 2025 Financial Guidance and Reaffirms Fiscal Year 2025 Financial Guidance 2024-10-08 20:30
Korea's SK bioscience Acquires Stake in U.S. Biotech Fina Biosolutions 2024-10-08 20:00
Pierre Fabre Laboratories and Scorpion Therapeutics Announce First Patient Dosed in Phase I/II Clinical Trial of PFL-241/STX-241, a Mutant-Selective Inhibitor Intended To Treat Locally Advanced or Metastatic Non-Small Cell Lung Cancer 2024-10-08 20:00
MicuRx Pharmaceuticals Announces Promising Results from MRX-5 Study for Treating Mycobacterium abscessus Infections 2024-10-08 13:38
Registrational Phase III Studies of APG-2449 Cleared by China CDE for the Treatment of Patients with NSCLC 2024-10-08 10:26
Sciwind Biosciences Announces Oral Presentation on Oral GLP-2 Research Progress at the 32nd United European Gastroenterology Week (UEG Week 2024) 2024-10-08 10:00
MediLink Announces Global Clinical Trial Collaboration and Supply Agreement on YL201 Combination Therapy 2024-10-08 08:00
Innovent and Ask Pharm Announce Strategic Collaboration for Limertinib, a Third-generation EGFR TKI for the Treatment of Lung Cancer 2024-10-08 08:00
Australian TGA Approves Additional Indication for Telix's Illuccix® to Include Patient Selection for PSMA-Targeted Therapy 2024-10-08 04:00
The U.S. Fish and Wildlife Service Rejects Petition to List Long-Tailed Macaques Under the Endangered Species Act 2024-10-08 03:31
GBI Biomanufacturing and Allterum Therapeutics Announce Strategic Collaboration to Manufacture Therapeutic Antibody for Clinical Trials 2024-10-08 00:00
Antengene to Present Results from Three Programs at the 2024 SITC Annual Meeting 2024-10-07 13:14
Sirnaomics Has Been Subscribed for 17,527,696 Subscription Shares, New Capital Injection to Promote Business Growth and Development 2024-10-04 13:03
1 15 16 17 18 19 458